EYEN Eyenovia, Inc. Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

Settings

EYEN [NASD]

Eyenovia, Inc.

Healthcare | Biotechnology | USA

statements

Index	-	P/E	-	EPS (ttm)	-1.10	Insider Own	26.20%	Shs Outstand	22.21M	Perf Week	2.99%
Market Cap	86.66M	Forward P/E	-	EPS next Y	-0.91	Insider Trans	17.15%	Shs Float	15.24M	Perf Month	-4.70%
Income	-20.80M	PEG	-	EPS next Q	-0.21	Inst Own	7.20%	Short Float	0.33%	Perf Quarter	1.17%
Sales	-	P/S	-	EPS this Y	19.00%	Inst Trans	36.85%	Short Ratio	0.28	Perf Half Y	19.38%
Book/sh	0.84	P/B	4.11	EPS next Y	8.10%	ROA	-124.40%	Target Price	-	Perf Year	-3.63%
Cash/sh	0.91	P/C	3.78	EPS next 5Y	-	ROE	-163.10%	52W Range	1.11 - 6.92	Perf YTD	-22.99%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-50.14%	Beta	-
Dividend %	-	Quick Ratio	3.80	Sales past 5Y	-	Gross Margin	-	52W Low	210.81%	ATR	0.18
Employees	27	Current Ratio	3.80	Sales Q/Q	-	Oper. Margin	-	RSI (14)	55.53	Volatility	4.40% 5.31%
Optionable	Yes	Debt/Eq	0.03	EPS Q/Q	19.70%	Profit Margin	-	Rel Volume	1.37	Prev Close	3.40
Shortable	Yes	LT Debt/Eq	0.02	Earnings	Nov 10 AMC	Payout	-	Avg Volume	180.23K	Price	3.45
Recom	1.70	SMA20	2.56%	SMA50	2.33%	SMA200	4.31%	Volume	245,602	Change	1.47%

Feb-03-20

Downgrade

Oppenheimer

Outperform → Perform

Nov-10-20 04:06PM	Eyenovia Reports Third Quarter 2020 Financial Results GlobeNewswire
02:45PM	Eyenovia, Inc. to Host Earnings Call ACCESSWIRE
Nov-09-20 03:30PM	These 3 Penny Stocks Could Rally Over 100%, Says Roth Capital TipRanks
Nov-05-20 08:00AM	Eyenovia to Report Third Quarter 2020 Results on Tuesday, November 10 GlobeNewswire
Oct-13-20 03:40PM	Bausch Acquires License for Myopia Solution from Eyenovia Zacks
07:00AM	Eyenovia to Host Investor Call to Discuss Recent Licensing Agreements Resulting in Total Potential License Payments and Development Cost Reimbursement and Savings of Approximately $100 Million GlobeNewswire
Oct-12-20 07:00AM	Bausch Health Licenses Eyenovia's Investigational Treatment For The Reduction Of Pediatric Myopia Progression In Children Ages 3-12 PR Newswire +5.60%
Oct-05-20 07:00AM	Eyenovia to Present Clinical Study Updates at the American Academy of Optometry Annual Meeting Business Wire
Sep-09-20 08:30AM	Eyenovia to Present at the 22nd Annual H.C. Wainwright Global Investment Conference GlobeNewswire
Aug-26-20 07:31AM	Stuart Grant Just Bought 9.0% More Shares In Eyenovia, Inc. (NASDAQ:EYEN) Simply Wall St.
Aug-24-20 08:30AM	Eyenovia, Inc. Announces Underwriters Full Exercise of Over-Allotment Option in Public Offering GlobeNewswire
Aug-21-20 04:05PM	Eyenovia, Inc. Announces Closing of Offering of Common Stock GlobeNewswire
Aug-19-20 09:10AM	Eyenovia, Inc. Prices Public Offering of Common Stock GlobeNewswire -16.70%
Aug-18-20 04:03PM	Eyenovia, Inc. Announces Proposed Public Offering of Common Stock GlobeNewswire
Aug-12-20 04:05PM	Eyenovia Reports Second Quarter 2020 Financial Results GlobeNewswire
07:29AM	The Daily Biotech Pulse: India Globalization Gets Nod For Alzheimer's Trial, Moderna's Vaccine Deal With US, Cellular Biomedicine To Go Private Benzinga
Aug-11-20 08:00AM	Eyenovia and Arctic Vision Announce Exclusive Collaboration and License Agreement to Develop and Commercialize MicroPine and MicroLine in Greater China and South Korea GlobeNewswire +38.19%
Jul-29-20 08:30AM	Eyenovia Announces Conference Call and Webcast for Second Quarter 2020 Financial Results GlobeNewswire
Jul-20-20 03:30PM	3 Strong Buy Healthcare Stocks Under $5 That Could Double (Or More) TipRanks +8.89%
Jun-30-20 04:05PM	Eyenovia Resumes Recruitment of Phase III CHAPERONE Study for Progressive Myopia GlobeNewswire
Jun-11-20 04:10PM	Eyenovia, Inc. Announces Adjournment of 2020 Annual Meeting of Stockholders to June 30, 2020 and Change to a Virtual Meeting Format GlobeNewswire
Jun-05-20 04:10PM	Eyenovia Announces Intention to Adjourn 2020 Annual Meeting of Stockholders to June 30, 2020 and Change to a Virtual Meeting Format GlobeNewswire
May-13-20 04:05PM	Eyenovia Reports First Quarter 2020 Financial Results GlobeNewswire -5.51%
May-06-20 08:30AM	Eyenovia Announces Conference Call and Webcast for First Quarter 2020 Financial Results GlobeNewswire
Apr-22-20 10:10AM	Will Eyenovia Continue to Surge Higher? Zacks
Mar-26-20 06:31AM	Insider Buying: Stuart Grant Just Spent US$1.9m On Eyenovia, Inc. (NASDAQ:EYEN) Shares Simply Wall St.
Mar-25-20 04:05PM	Eyenovia Reports Fourth Quarter and Full Year 2019 Financial Results GlobeNewswire
02:30PM	Eyenovia, Inc. to Host Earnings Call ACCESSWIRE
Mar-24-20 05:10PM	Eyenovia, Inc. Announces Closing of Approximately $6.0 Million Private Placement GlobeNewswire +8.26%
Mar-23-20 06:35PM	Eyenovia, Inc. Announces Approximately $6.0 Million Private Placement GlobeNewswire
Mar-11-20 08:30AM	Eyenovia Announces Conference Call and Webcast for Fourth Quarter and Full-Year 2019 Financial Results GlobeNewswire
Mar-04-20 08:30AM	Eyenovia to Participate in Two Upcoming Investor Conferences GlobeNewswire
Feb-17-20 07:33AM	How Does Eyenovia, Inc. (NASDAQ:EYEN) Affect Your Portfolio Volatility? Simply Wall St.
Feb-10-20 09:25AM	Zoetis (ZTS) to Report Q4 Earnings: What's in the Cards? Zacks
Dec-19-19 09:55AM	Have Insiders Been Buying Eyenovia, Inc. (NASDAQ:EYEN) Shares? Simply Wall St. +12.39%
08:30AM	Eyenovia Expands Scientific Advisory Board with Two Experts in Optometry GlobeNewswire
Dec-02-19 09:02AM	Eyenovia, Inc. (EYEN) Shares March Higher, Can It Continue? Zacks -6.06%
Nov-27-19 09:00AM	All You Need to Know About Eyenovia, Inc. (EYEN) Rating Upgrade to Strong Buy Zacks +14.53%
Nov-13-19 04:05PM	Eyenovia Reports Third Quarter 2019 Financial Results GlobeNewswire +5.24%
Nov-12-19 10:42AM	Can European Buyouts Aid Canopy Growth's (CGC) Q2 Earnings? Zacks -7.29%
08:23AM	What's in Store for Applied Materials' (AMAT) Q4 Earnings? Zacks
Nov-11-19 11:24AM	Can Cannabis Therapy Drive Canopy Growth's (CGC) Q2 Earnings? Zacks
09:42AM	Overstock (OSTK) to Report Q3 Earnings: What's in Store? Zacks
07:50AM	5 Biotech Stocks Set to Beat Q3 Earnings Estimates Zacks
Nov-07-19 11:15AM	Cronos (CRON) to Report Q3 Earnings: What's in the Cards? Zacks
10:32AM	Tilray (TLRY) to Report Q3 Earnings: What's in the Cards? Zacks
Nov-06-19 09:56AM	Mettler-Toledo (MTD) to Post Q3 Earnings: What's in Store? Zacks +7.12%
Nov-05-19 11:50AM	CannTrust (CTST) to Report Q3 Earnings: What's in Store? Zacks
11:24AM	What's in Store for Cumberland Pharma (CPIX) in Q3 Earnings? Zacks
11:13AM	Zoetis (ZTS) to Report Q3 Earnings: What's in the Cards? Zacks
Nov-04-19 11:42AM	What's in the Cards for Zynerba (ZYNE) This Earnings Season? Zacks
10:56AM	EPAM Systems (EPAM) to Post Q3 Earnings: What's in Store? Zacks
10:49AM	TiVo (TIVO) to Report Q3 Earnings: What's in the Cards? Zacks
10:22AM	Expedia Group's (EXPE) to Post Q3 Earnings: What's in Store? Zacks
10:01AM	Factors to Consider Ahead of Cutera's (CUTR) Q3 Earnings Zacks
09:10AM	Factors Setting the Tone for Square's (SQ) Earnings in Q3 Zacks
Oct-31-19 10:47AM	Can Segmental Growth Aid Hologic (HOLX) in Q4 Earnings? Zacks
08:30AM	Eyenovia Announces Conference Call and Webcast for Third Quarter 2019 Financial Results GlobeNewswire
Oct-30-19 07:01AM	The Daily Biotech Pulse: Novartis Program Placed On Partial Clinical Hold, Adcom Snub For Amag, Amgen Earnings Benzinga -7.32%
Oct-29-19 04:05PM	Eyenovia Advances MicroLine for the Treatment of Presbyopia Towards Phase III Development and Reprioritizes Late-Stage Ophthalmology Pipeline GlobeNewswire -5.63%
Oct-02-19 08:30AM	Eyenovia to Participate in Multiple Upcoming Medical Meetings GlobeNewswire
Sep-19-19 12:07PM	Do Insiders Own Lots Of Shares In Eyenovia, Inc. (NASDAQ:EYEN)? Simply Wall St.
Sep-03-19 08:30AM	Eyenovia to Present at Two Upcoming Investor Conferences GlobeNewswire
Aug-12-19 02:30PM	Eyenovia, Inc. to Host Earnings Call ACCESSWIRE
Aug-06-19 08:30AM	Eyenovia Announces Conference Call and Webcast for Second Quarter 2019 Financial Results GlobeNewswire
Jul-16-19 04:05PM	Eyenovia, Inc. Announces Underwriters Full Exercise of Over-Allotment Option in Public Offering GlobeNewswire +10.74%
Jul-15-19 07:15PM	Eyenovia Inc (EYEN) CEO Tsontcho Ianchulev Bought $650,000 of Shares GuruFocus.com
04:30PM	Eyenovia, Inc. Announces Closing of Public Offering GlobeNewswire
Jul-11-19 11:13AM	Did Eyenovia, Inc. (NASDAQ:EYEN) Insiders Buy Up More Shares? Simply Wall St. -17.48%
09:00AM	Eyenovia, Inc. Prices Public Offering of Common Stock GlobeNewswire
Jul-10-19 04:07PM	Eyenovia, Inc. Announces Proposed Public Offering of Common Stock GlobeNewswire -14.17%
Jun-04-19 08:30AM	Eyenovia Enrolls First Patient in Phase III CHAPERONE Study for Progressive Myopia GlobeNewswire
May-14-19 06:30AM	Eyenovia Reports First Quarter 2019 Financial Results GlobeNewswire -15.11%
May-06-19 10:53AM	Introducing Eyenovia (NASDAQ:EYEN), The Stock That Dropped 33% In The Last Year Simply Wall St.
May-01-19 08:30AM	Eyenovia Announces Conference Call and Webcast for First Quarter 2019 Financial Results GlobeNewswire +5.35%
Mar-27-19 06:30AM	Eyenovia Reports Fourth Quarter and Full Year 2018 Financial Results GlobeNewswire
Mar-13-19 08:30AM	Eyenovia Announces Conference Call and Webcast for Fourth Quarter and Full-Year 2018 Financial Results GlobeNewswire
Mar-04-19 08:30AM	Eyenovia to Participate in Two Upcoming Investor Conferences GlobeNewswire
Feb-25-19 08:30AM	Eyenovia Announces Confirmatory Results from Second MicroStat Phase III Registration Study for Mydriasis GlobeNewswire +5.04%
Feb-13-19 08:30AM	Eyenovia confirms expanded MicroProst Phase III indication to enroll broad patient population for IOP lowering GlobeNewswire
Feb-06-19 08:30AM	Eyenovia Announces FDA Acceptance of IND Application for MicroPine to Reduce the Progression of Myopia GlobeNewswire +13.64%
Feb-05-19 08:00AM	Biotech Stocks to Watch ACCESSWIRE +7.18%
Jan-31-19 08:30AM	Biotechs Investors Are Flocking To ACCESSWIRE +6.38%
Jan-30-19 09:35AM	4 Healthcare Stocks Raising The Bar On Wednesday (1/30/19) ACCESSWIRE +25.10%
07:56AM	Eyenovia shares rocket on positive results in trial of device used to cause dilation of the eye MarketWatch
07:00AM	Eyenovia Announces Positive Results in the MicroStat MIST-1 Phase III Registration Study for Mydriasis GlobeNewswire
Dec-25-18 01:39PM	Do Institutions Own Eyenovia, Inc. (NASDAQ:EYEN) Shares? Simply Wall St.
Dec-19-18 02:45PM	4 Healthcare Stocks to Watch on Wednesday (12/19/18) ACCESSWIRE
09:05AM	Eyenovia Prices Public Offering of Common Stock GlobeNewswire
Dec-03-18 09:00AM	Eyenovia Completes Patient Enrollment in MicroStat MIST-1 Study and Enrolls First Patient in MIST-2 Study GlobeNewswire +18.77%
Nov-28-18 04:05PM	Eyenovia Announces Publication of its PG21 Phase II Trial Results Demonstrating Robust IOP Lowering Effect and Patient Usability GlobeNewswire
Nov-27-18 10:44AM	Eyenovia Initiates Phase III Study for Mydriasis Candidate Zacks +11.11%
07:32AM	The Daily Biotech Pulse: Abeona Fires CEO, Loxo Passes FDA Muster, Bristol-Myers Flunks Lung Cancer Trial Benzinga
Nov-26-18 05:26PM	Eyenovia Initiates Phase III MicroStat Program for Pharmacologic Mydriasis: Enrolls First Patient in MIST-1 Study PR Newswire +10.77%
09:00AM	Eyenovia Initiates Phase III MicroStat Program for Pharmacologic Mydriasis: Enrolls First Patient in MIST-1 Study GlobeNewswire
Nov-21-18 08:50AM	Market Trends Toward New Normal in Wilhelmina International, Eyenovia, aTyr Pharma, Avinger, Viacom, and Axsome Therapeutics Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire -6.99%
Nov-13-18 07:30AM	Eyenovia Announces FDA Acceptance of MicroStat IND Application for Mydriasis GlobeNewswire -15.38%
06:30AM	Eyenovia Reports Third Quarter 2018 Financial Results GlobeNewswire
Nov-01-18 08:30AM	Eyenovia Announces Conference Call and Webcast for Third Quarter 2018 Financial Results GlobeNewswire
Oct-23-18 09:00AM	Eyenovia to Present at the Ophthalmology Innovation Summit at the American Academy of Ophthalmology 2018 GlobeNewswire

Eyenovia, Inc., a clinical stage ophthalmic biopharmaceutical company, engages in developing a pipeline of microdose therapeutics utilizing its patented piezo-print delivery technology, branded the Optejet. It focuses on achieving clinical microdosing of next-generation formulations of ophthalmic pharmaceutical agents using its ocular delivery system, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance, and topical delivery success for ophthalmic eye treatments. The company, through its proprietary delivery technology, is developing smart ophthalmic therapies while targeting new indications for which there are currently no drug therapies approved by the U.S. Food and Drug Administration. Eyenovia, Inc. focuses on advancing its MicroLine program for the improvement in near vision in patients with presbyopia in Phase III development. Its other product candidates include MicroProst, which is in Phase III clinical trials for the treatment of chronic angle closure glaucoma, open angle glaucoma, and ocular hypertension; MicroStat, which has completed Phase III clinical trials for the treatment of mydriasis; MicroTears for the treatment of red eye and itch relief lubrication; and MicroPine for the treatment of progressive myopia. The company was formerly known as PGP Holdings V, Inc. and changed its name to Eyenovia, Inc. in May 2014. Eyenovia, Inc. was founded in 2014 and is based in New York, New York.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
GANDOLFO JOHN P	Chief Financial Officer	Nov 19	Buy	3.40	4,000	13,600	6,000	Nov 23 04:05 PM
Grant Stuart M.	10% Owner	Oct 12	Buy	3.55	100,000	355,000	4,219,748	Oct 13 11:54 AM
Grant Stuart M.	10% Owner	Sep 24	Buy	2.99	75,000	224,500	4,119,748	Sep 25 01:42 PM
Clasby Jennifer G	VP, Clinical Operations	Sep 18	Option Exercise	1.95	26,737	52,137	55,702	Oct 16 05:04 PM
Grant Stuart M.	10% Owner	Aug 20	Buy	2.06	451,620	929,434	4,044,748	Aug 24 06:05 AM
Grant Stuart M.	10% Owner	Aug 19	Buy	3.60	333,000	1,198,800	3,593,128	Aug 24 06:05 AM
MARIO ERNEST	Director	Mar 24	Buy	2.27	82,431	187,118	327,239	Mar 26 06:12 PM
Ianchulev Tsontcho	Chief Executive Officer	Mar 24	Buy	2.27	82,431	187,118	508,679	Mar 26 06:17 PM
Grant Stuart M.	10% Owner	Mar 23	Buy	2.06	903,240	1,858,868	3,260,128	Mar 25 05:51 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience